Chair, Distinguished Delegates,

We speak on behalf of a constituency committed to advancing action on noncommunicable diseases, with a focus on circulatory health—cardiovascular diseases (including heart disease and stroke), diabetes, kidney disease, and chronic respiratory conditions. These are leading causes of NCD deaths and impose substantial health and economic burdens.

Despite shared, modifiable risk factors, these conditions remain underdiagnosed, undertreated, and underfunded, particularly in low- and middle-income countries. Ahead of the 2025 High-Level Meeting, circulatory health must be prioritized in political and funding commitments.

We welcome the proposed WHO Resolution on noncommunicable diseases through promotion of kidney health and strengthening prevention and control of kidney disease and emphasize its relevance to broader circulatory health. Cardiovascular diseases, diabetes, and kidney disease are preventable and manageable through integrated, cost-effective interventions. Improving kidney health is a strategic entry point for strengthening the response to circulatory conditions and advancing SDG 3.4.

We urge Member States to:
● Integrate prevention and early detection of circulatory conditions into UHC primary care;
● Ensure equitable access to diagnostics, medicines, and health workforce training, through primary care , to improve care for multimorbidity and support, medication management;
● Strengthen information systems across the circulatory health spectrum;

We call on WHO to:
● Support integrated circulatory care using evidence-based tools;
● Promote cross-sectoral coordination to address social and environmental determinants;